(Q40233569)
Statements
Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America (English)
Gustavo H Dayan
Luis Á Villar
Doris M Rivera-Medina
Mark Boaz
Linda Starr-Spires
Manoj Thakur
Betzana Zambrano
María C Miranda